Home » Newsletters » The Carlat Child Psychiatry Report

The Carlat Child Psychiatry Report

Psychotropic Risks in Children and Adolescents (May/June) | 2018

View Archived Issues

CME Post-Test - Psychotropic Risks in Children and Adolescents, CCPR, May/June 2018

The post-test for this issue is available for one year after the publication date to subscribers. By successfully completing the test you will be awarded a certificate for 2 CME credits. Read More

Informed Consent: An Ongoing Process for Focused Care

Informed consent is a foundation for good clinical practice and can provide legal protection. But informed consent is more than defensive medicine. It is a vehicle for framing good care. How often do people use the consent process? Read More

Embracing Conflict in the Consent Process

What do you do when your teen patient declines an offer of medication yet the parents insist on it? How about if the teen is coming to you for medication and the parents are opposed to the idea? Read More

Considerations When Prescribing Psychotropic Medications

How do you approach using psychotropic medications for children and adolescents? Most parents do not want to start medications. I empathize with them, which then makes it possible to move together toward medications when indicated. Read More

Metformin to Control Antipsychotic-Induced Weight Gain in Children

Metformin has been used off-label for weight loss in psychiatry for many years, much of it for help with adult weight gain as a side effect of atypical antipsychotics. However, most trials of metformin for weight loss were actually conducted on the child and adolescent population. This article will look at the quality of the data in our pediatric population of 3 studies, and then come up with some recommendations for your practice. Read More